2024
A Multicenter Evaluation of the Impact of Therapies on Deep Learning-based Electrocardiographic Hypertrophic Cardiomyopathy Markers
Dhingra L, Sangha V, Aminorroaya A, Bryde R, Gaballa A, Ali A, Mehra N, Krumholz H, Sen S, Kramer C, Martinez M, Desai M, Oikonomou E, Khera R. A Multicenter Evaluation of the Impact of Therapies on Deep Learning-based Electrocardiographic Hypertrophic Cardiomyopathy Markers. The American Journal Of Cardiology 2024 PMID: 39581517, DOI: 10.1016/j.amjcard.2024.11.028.Peer-Reviewed Original ResearchCleveland Clinic FoundationHypertrophic cardiomyopathyMedian follow-up periodHypertrophic cardiomyopathy therapyMonitoring treatment responseFollow-up periodImpact of therapyAtlantic Health SystemLack of improvementOral alternativePost-SRTMedical therapyTreatment responseMulticenter evaluationInterventricular septumPercutaneous reductionMavacamtenTherapyPatientsClinic FoundationPoint-of-care monitoringECGECG imagesScoresHealth system
2020
Recommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists
Aminorroaya A, Vasheghani-Farahani A, Masoudkabir F, Roayaei P. Recommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists. Journal Of Interventional Cardiac Electrophysiology 2020, 60: 1-7. PMID: 32712900, DOI: 10.1007/s10840-020-00837-4.Peer-Reviewed Original ResearchConceptsSudden cardiac deathImplantable cardioverter-defibrillatorHypertrophic cardiomyopathySudden cardiac death risk stratificationEuropean Society of Cardiology guidelinesPrimary prevention implantable cardioverter-defibrillatorRisk stratification of patientsAmerican College of Cardiology Foundation/American Heart AssociationImplantable cardioverter-defibrillator implantationHigh-risk patientsStratification of patientsImplantation of primary prevention implantable cardioverter-defibrillatorsCardioverter-defibrillator implantationCardiology guidelinesRisk patientsVentricular arrhythmiasClinical outcomesCardiac deathCardioverter-defibrillatorHeart AssociationAmerican CollegePrimary preventionPatientsCare practitionersEuropean Society